The MESOMARK Assay, a blood test developed to monitor patients with mesothelioma–a form of cancer caused by asbestos exposure–is now available to physicians in the U.S..  The test, which can be used to help manage the care of patients with epitheloid or biphasic mesothelioma, requires only a blood sample to be taken from the patient. […]

The MESOMARK Assay, a blood test developed to monitor patients with asbestos exposure–is now available to physicians in the U.S..  The test, which can be used to help manage the care of patients with epitheloid or biphasic mesothelioma, requires only a blood sample to be taken from the patient. The MESOMARK was recently approved by the U.S. Food and Drug Administration (FDA) under the agency’s Humanitarian Device Exemption (HDE) program. Mesothelioma is a form of cancer mainly affecting people exposed to asbestos in the workplace.

Mesothelioma Information continued….

How To Successfully Treat Cancer Using Inexpensive, Proven, Natural Therapies. DETAILS HERE